Tooth DiseaseNCT07524842
Clinical Performance of Three Different Restorative Materials
A study testing bioactive composite, nanohybrid resin composite and bulk-fill resin composite in people with Tooth Disease, run by Hacettepe University.
Trial summary
The clinical performance of a bioactive composite (alkasite-based), a nanohybrid resin composite and a bulk-fill resin composite in class II restorations will be evaluated and compared. After recruiting participants with at least 3 approximal caries lesions, all restorations will be placed by a single clinician. Read more about this study
- Who is it for?
- Ages 18 to 65 yearsHealthy volunteers can take part
- Conditions the study is for
- Tooth Disease
- What is being tested?
- bioactive composite, nanohybrid resin composite and bulk-fill resin composite
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 60 participants
- Where
- No sites listed yet
- Study dates
- 28 Apr 2026to 28 Jun 2028
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 65 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- age range will be 18 to 65
- patients should have at least 3 approximal caries lesions require restoration
- healthy periodontal status
- a good likelihood of recall availability
Who cannot join
- poor gingival health
- adverse medical history
- potential behavioral problems
About this study
Official title: Clinical Performance of Three Different Restorative Materials-Nanohybrid, Bulk-fill, and Alkasite-based
The clinical performance of a bioactive composite (alkasite-based), a nanohybrid resin composite and a bulk-fill resin composite in class II restorations will be evaluated and compared. After recruiting participants with at least 3 approximal caries lesions, all restorations will be placed by a single clinician. All caries lesions will be removed before restoring. Cavities will be divided into three groups: a bioactive composite [Cention Forte Ivoclar Vivadent, Schaan, Liechtenstein], a nanohybrid resin composite [Tetric N-Ceram2 (Ivoclar Vivadent, Schaan, Liechtenstein)] and a bulk-fill resin composite [Tetric N-PowerFill2 (Ivoclar Vivadent, Schaan, Liechtenstein)], All restorative procedures will be conducted according to manufacturers' instructions. Restorations will be scored using FDI criteria after a week (baseline) 6, 12, 24, 36 and 48 months. Descriptive statistics will be performed using chi-square tests.
- Conditions
- Tooth Disease
- Being tested
- bioactive composite, nanohybrid resin composite, bulk-fill resin composite
- Medical subject headings
- Tooth Diseases
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
bioactive compositeDevice
bioactive composite restoration
nanohybrid resin compositeDevice
nanohybrid resin composite restoration
bulk-fill resin compositeDevice
bulk-fill resin composite restoration
| Study group | Role | What they receive |
|---|---|---|
| bioactive composite | Experimental | Cention Forte Ivoclar Vivadent, Schaan, Liechtenstein Receives: Device: bioactive composite |
| nanohybrid resin composite | Experimental | Tetric N-Ceram2 (Ivoclar Vivadent, Schaan, Liechtenstein) Receives: Device: nanohybrid resin composite |
| bulk-fill resin composite | Experimental | Tetric N-PowerFill2 (Ivoclar Vivadent, Schaan, Liechtenstein) Receives: Device: bulk-fill resin composite |
What is being measured
The primary outcome is the main question the study is designed to answer.
Clinical performances of different restorative systems according to FDI criteria
Two year results according to FDI criteria (scores 1-5, 1-very good, 5-poor/replace)
Measured: two years
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted13 Apr 2026
- Study start28 Apr 2026 (estimated)
- Primary completion28 Jun 2026 (estimated)
- Study completion28 Jun 2028 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Tooth DiseaseStudies of the same condition, open and under way.
- More trials run by Hacettepe UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 60 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Hacettepe University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Dr. Fatma Dilşad Öz, Hacettepe University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07524842
- Sponsor's protocol ID
- bioactive-alkasite
- Status last verified
- Apr 2026
- First submitted
- 6 Apr 2026
- Last updated
- 1 May 2026
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 1 May 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Clinical Performance of Three Different Restorative Materials-Nanohybrid, Bulk-fill, and Alkasite-based
- ClinicalTrials.gov ID
- NCT07524842
- Acronym / sponsor ID
- bioactive-alkasite
- Conditions
- Tooth Disease
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 60 participants (estimated)
- Lead sponsor
- Hacettepe UniversityUniversity, hospital or other
- Study start
- 28 Apr 2026 (estimated)
- Primary completion
- 28 Jun 2026 (estimated)
- Study completion
- 28 Jun 2028 (estimated)
- First posted
- 13 Apr 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The clinical performance of a bioactive composite (alkasite-based), a nanohybrid resin composite and a bulk-fill resin composite in class II restorations will be evaluated and compared. After recruiting participants with at least 3 approximal caries lesions, all restorations will be placed by a single clinician. All caries lesions will be removed before restoring. Cavities will be divided into three groups: a bioactive composite [Cention Forte Ivoclar Vivadent, Schaan, Liechtenstein], a nanohybrid resin composite [Tetric N-Ceram2 (Ivoclar Vivadent, Schaan, Liechtenstein)] and a bulk-fill resin composite [Tetric N-PowerFill2 (Ivoclar Vivadent, Schaan, Liechtenstein)], All restorative procedures will be conducted according to manufacturers' instructions. Restorations will be scored using FDI criteria after a week (baseline) 6, 12, 24, 36 and 48 months. Descriptive statistics will be performed using chi-square tests.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (participant)
- Number of arms
- 3
| Arm | Type | Receives |
|---|---|---|
| bioactive composite | Experimental | Device: bioactive compositeCention Forte Ivoclar Vivadent, Schaan, Liechtenstein |
| nanohybrid resin composite | Experimental | Device: nanohybrid resin compositeTetric N-Ceram2 (Ivoclar Vivadent, Schaan, Liechtenstein) |
| bulk-fill resin composite | Experimental | Device: bulk-fill resin compositeTetric N-PowerFill2 (Ivoclar Vivadent, Schaan, Liechtenstein) |
Who may qualify
- Ages
- 18 to 65 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (4 listed)
- age range will be 18 to 65
- patients should have at least 3 approximal caries lesions require restoration
- healthy periodontal status
- a good likelihood of recall availability
Key exclusion criteria (3 listed)
- poor gingival health
- adverse medical history
- potential behavioral problems
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| bioactive compositebioactive composite restoration | Device | bioactive composite |
| nanohybrid resin compositenanohybrid resin composite restoration | Device | nanohybrid resin composite |
| bulk-fill resin compositebulk-fill resin composite restoration | Device | bulk-fill resin composite |
Primary outcome
Clinical performances of different restorative systems according to FDI criteria
Time frame: two years
Two year results according to FDI criteria (scores 1-5, 1-very good, 5-poor/replace)
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 1 May 2026.
- Individual participant dataSharing planned: No
Related trials for Tooth Disease
Not yet recruiting
PRP-Assisted Regenerative Endodontics Versus Conventional Root Canal Treatment in Mature Necrotic Teeth
Pulp Necrosis, Apical Periodontitis
Active, not recruiting
L-PRF Block vs Composite Graft for Horizontal Ridge Augmentation
Alveolar Ridge Resorption After Extraction, Alveolar Bone Loss
Enrolling by invitation
Discision as Acceleration Method in Canine Retraction in Orthodontics With Aligner and Fixed Appliances in Young Adults a Split Mouth Study
Bimaxillary Protrusion, Class II Div 1 Malocclusion
RecruitingObservational study
Studying Nerve Function and Structure in Charcot-Marie-Tooth Disease, Anti-MAG Neuropathy and CIDP
Charcot-Marie-Tooth, CMT1A
Not yet recruiting
Safety Assessment of Placing a Single Dental Implant Without Antibiotic Prophylaxis in Simple Cases: A Pilot Study
Tooth Loss and Rehabillitation, Dental Implant Failure
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
The record lists no contact. Use the official record to reach the sponsor.
Questions about this trial
What is this clinical trial studying?
A study testing bioactive composite, nanohybrid resin composite and bulk-fill resin composite in people with Tooth Disease, run by Hacettepe University.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 1 May 2026. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Clinical performances of different restorative systems according to FDI criteria (time frame: two years). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 May 2026.